Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021
HomeEXECUTIVESJoe DiPaolo New CEO of The Orthopedic Institute of New Jersey: Proven Track Record in Orthopedic Service

Joe DiPaolo New CEO of The Orthopedic Institute of New Jersey: Proven Track Record in Orthopedic Service

January 28, 2021

Joe DiPaolo has an extensive career in health care management includes almost two decades of top-level leadership and unique specialization in orthopedic services.

Joe DiPaolo joins The Orthopedic Institute of New Jersey (OINJ) during an exciting time of continued growth and expansion for the practice, which now boasts 24 providers in eight locations throughout north and central New Jersey.

Our goal is to continue the trajectory of our high-quality service delivery model, which is geared towards bringing our team of orthopedic specialists to convenient, state-of-the-art facilities right in our patients’ neighborhoods,” said Robert A. DeFalco, Jr., DO, an orthopedic surgeon and principal partner at OINJ. “Joe’s experience and track record help us further operationalize and support these efforts on a larger scale and enable us to solidify our position as the premier destination for orthopedic care in our dedicated service areas as we expand.”

Joe DiPaolo comes from the Atlantic Health System, as the former president of the western New Jersey region, and held the position of CEO of Newton Medical Center.  In those roles, DiPaolo was charged with the oversight of two acute care hospitals and multiple outpatient facilities. He was directly responsible for all region operations and for ensuring the quality, safety, and financial integrity of the hospitals and their ambulatory operations. His direct system-wide shared service role included managing the orthopedic service line as well as the supply chain, emergency management, and environmental operations, among others.

Most recently, as a consultant, he held the title of Interim Senior Operations Executive for both the city of Chicago and the state of Maryland, tasked with the startup and ongoing operations of all COVID-19 field hospitals in those diverse locations. In this crucial role, he was responsible for the design and implementation of all contracting and management of critical supplies and resources. A fellow in the American College of Healthcare Executives, DiPaolo holds an MBA in finance from the Fordham Gabelli School of Business and an undergraduate degree in business informatics from the George Washington University School of Business.

Joe DiPaolo said, “My background and passion are helping organizations achieve their vision by bringing a blend of innovative and proven solutions to the complexities of the healthcare business model. Ultimately the strength and stability of any clinical organization both depend on and are reflected in the point-of-care delivery.”

DiPaolo was brought on board to execute against this vision for OINJ as it grows and to direct the OINJ team in the core functional areas of finance, operations, marketing, and integration of clinical and business technologies. Additionally, his background in skillfully guiding, managing, and working across and with multiple stakeholders will serve OINJ well as it partners with like-minded groups, including referring networks, community leaders, and accountable care organizations (ACOs). DiPaolo’s proven record of excellence in clinical care leadership, as well as his astute attention to call center operations, procurement of resources, quality, and safety, made him the best fit for this top orthopedic practice.

On Joe DiPaolo experience and track record, Dr. DeFalco, who specializes in sports medicine and treatment of the shoulder, knee, and hip, added,” Joe DiPaolo’s experience and track record, specifically in orthopedic service delivery, are second to none. His leadership ensures our practice will continue to excel inpatient care as well as the operations that serve as the foundation of our business.”

About taking the helm at OINJ, Joe DiPaolo ended, “I’m delighted to join this dynamic, thriving, and well-respected practice. I was attracted to this opportunity because it allows me to leverage my deep experience as a healthcare executive, especially in this tri-state area. OINJ and I are well-matched in our high level of commitment to excellence in patient care and quality service delivery. I look forward to collaborating with this outstanding group of healthcare professionals and guiding the practice as it grows.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy